CBG(000009)2025-04-15 11:50Financial Performance - The company's operating revenue for 2024 was ¥20,227,883,804.41, a decrease of 34.10% compared to ¥30,697,118,102.02 in 2023[19] - The net profit attributable to shareholders for 2024 was ¥172,625,210.40, down 77.18% from ¥756,459,343.67 in 2023[19] - The net cash flow from operating activities decreased by 72.11% to ¥1,662,423,468.08 in 2024 from ¥5,961,670,281.05 in 2023[19] - Basic earnings per share for 2024 were ¥0.0669, a decline of 77.19% compared to ¥0.2933 in 2023[19] - The company reported a significant decline in net profit excluding non-recurring gains and losses, which was ¥29,665,846.39 in 2024, down 95.56% from ¥667,591,931.61 in 2023[19] - The weighted average return on net assets for 2024 was 1.73%, down from 7.91% in 2023, indicating a decrease in profitability[19] - The company achieved total operating revenue of CNY 2,023,036.05 million, a decrease of 34.12% year-on-year[40] - The company's net profit attributable to shareholders was CNY 17,262.52 million, down 77.18% compared to the previous year[40] Cash Flow and Investments - The net cash flow from operating activities fell by 72.11% to approximately ¥1.66 billion in 2024, compared to ¥5.96 billion in 2023, primarily due to decreased sales revenue from subsidiaries[67] - The net cash flow from investment activities dropped by 96.70% to approximately -¥5.13 billion in 2024, attributed to increased capital expenditures for industrial base projects and reduced returns from financial products[67] - The net cash flow from financing activities increased by 154.94% to approximately ¥1.40 billion in 2024, driven by higher net financing from debt[67] - The net increase in cash and cash equivalents decreased by 355.07% to approximately -¥2.05 billion in 2024, reflecting reduced operating cash flow and increased investment cash outflows[67] Market and Industry Trends - The global sales of new energy vehicles reached 18.24 million units in 2024, a year-on-year increase of 24.4%, with China accounting for 12.87 million units, representing 70.5% of the global total[29] - The global output of energy storage cells is projected to be 330 GWh in 2024, reflecting a year-on-year growth of 58%[29] - The biopharmaceutical sector is under pressure, with the overall revenue of large-scale pharmaceutical enterprises in China remaining flat at ¥2.98 trillion in 2024, while profits slightly decreased by 0.9%[31] - The real estate market in China faced challenges, with new housing sales down 17.1% year-on-year in 2024, prompting the company to enhance operational efficiency and improve profitability[33] Strategic Focus and Development - The company is focusing on the high-tech industry, particularly in new energy materials and electric vehicles, aligning its strategy with national policies promoting green and low-carbon industries[28] - The company plans to continue developing new technologies and expanding its market presence in strategic emerging industries, particularly in new materials and precision manufacturing[29] - The company is actively developing new technologies in fast-charging anode materials, hydrogen energy, sodium-ion battery materials, and solid-state battery materials[41] - The company is focusing on enhancing cash flow and exploring growth points while adapting to new market conditions[40] Corporate Governance and Management - The company has established a governance structure that complies with legal and regulatory requirements, ensuring effective oversight and management[103] - The company maintains independence from major shareholders, with the largest shareholder holding only 18.39% of total shares, ensuring autonomous operational capabilities[105] - The company has undergone a complete board renewal with all directors and supervisors being elected on December 16, 2024[108] - The company is focused on enhancing its governance structure through the recent amendments to management procedures[126] Environmental Compliance and Sustainability - The company has obtained pollution discharge permits for various subsidiaries, with validity extending to 2029[152] - The company strictly adheres to multiple environmental protection laws and regulations in its operations[151] - The company is actively monitoring and managing its emissions to align with industry standards and regulations[154] - The company plans to enhance its wastewater treatment facilities to further reduce pollutant levels in compliance with updated regulations[157] Employee and Compensation Policies - The company employed a total of 16,658 staff members at the end of the reporting period, with 6,434 in production and 1,494 in sales[134][135] - The company has implemented a salary policy that emphasizes fairness and competitiveness, linking compensation to job value and performance[136] - Total remuneration for directors, supervisors, and senior management during the reporting period amounted to 30.40 million yuan[121] Community Engagement and Social Responsibility - 马应龙药业集团累计捐药捐款达到1.6亿元，2024年向多个地区捐赠物资总投入超1100万元[180] - 贝特瑞新材料集团向广东省教育基金会捐赠10,500册图书和9组书架，支持5所农村学校建设[181] - 印尼贝特瑞新能源材料有限公司向印尼Hanida基金会捐赠印尼盾30,000,000，帮助贫困地区的妇女儿童[182]